Why is Gerald waiting to unveil in NYC? First,
Post# of 30028
First, he has better control of the story in NYC unlike in Denmark. What media is going to cover him there? Lympro, if I am not mistaken, is initially geared for the United States. So, better that he unleash the news in the states at a conference where AMBS is the cosponser. There is no other story to get in the way like what would have been the case in Copenhagen.
2nd. As I touched above, more media outlets to get the story out. NYC just happens to be the #1 media market. What is Copenhagen? Get my point?
3rd. All the data isn't yet put together from what I gathered from what Gerald has written. The bridging of data isn't yet complete. Correct me if I am wrong.
In conclusion, NYC is the platform to launch Lympro. Bigger bang can be had there than in Copenhagen.
And some of you need to realize that ambs has a team that understands what they are doing. How many of you have ever done what they are doing? I doubt any, maybe one or two. Let the pros do their job while you relax behind your computer complaining about things that you really don't know about.
But if you have experience bringing diagnostics or drugs to market, please chime in so we can all get a better idea of how difficult and complex it is in today's highly regulated environment.